The incidence of osteoporosis in postmenopausal women was 34%.
绝经期妇女中骨质疏松发生率为34%。
This Paper reviewed the effect of exercise on osteoporosis in postmenopausal women.
综合分析了运动对妇女绝经后骨质疏松症的影响。
Raloxifene is also used in prevention and treatment of osteoporosis in postmenopausal women.
雷洛昔芬还被用于防治绝经后妇女骨质疏松症。
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
雷洛昔芬是用来预防和治疗绝经后妇女的骨质疏松症的。
In this paper the latest studies on the role of estrogen for the development of osteoarthritis and osteoporosis in postmenopausal women are reviewed.
本文介绍了国内外对雌激素在绝经后妇女骨关节炎和骨质疏松中作用的研究成果。
This review focuses on the potential mechanism and combined effect between estrogen replacement and exercise training so as to prevent and treat osteoporosis in postmenopausal women.
笔者就雌激素与运动防治绝经后骨质疏松症的可能作用机制及其联合作用效果的研究进展作一综述。
Objective:To evaluate the effect and safety of oral administration of residronate sodium in treatment of postmenopausal women with osteoporosis.
目的：探讨利塞膦酸钠治疗绝经后骨质疏松症的临床疗效，并评价其安全性。
Osteoporosis: of old postmenopausal women is the most important problem in the world, and that, it is also the important task of gerontology.
老年妇女绝经后骨质疏松是当今世界多数国家面临重要问题，也是老年医学的重要研究课题。
Objective To probe into the effects of vertebral bone size on the bone mineral density (BMD) and diagnosis of osteoporosis (OP) in postmenopausal women.
目的探讨绝经后妇女椎体骨骼大小对骨密度（BMD）和诊断骨质疏松（OP）的影响。
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?
在绝经后并且患有骨质疏松症的妇女中，颈动脉或者股动脉粥样硬化与低骨量之间的关系。骨保护素有作用吗。
Conclusions Etidronate may reduce the bone loss in castrated women, and exhibits active preventive effect on postmenopausal osteoporosis.
结论依替膦酸二钠可以减少去势手术妇女的骨量丢失，对预防去势手术妇女的骨质疏松有积极的作用。
OBJECTIVE: To evaluate the efficacy of exercise in postmenopausal women with osteoporosis.
目的：评价运动疗法治疗绝经后妇女骨质疏松症的疗效。
Clinical research has shown that the lack of estrogen in postmenopausal women with osteoporosis is a leading risk factors.
临床研究表明，雌激素缺乏是导致绝经后妇女骨质疏松的一个危险因素。
Results of the study showed that treatment with zoledronic acid was very effective in reducing the incidence of all types of fractures in women with postmenopausal osteoporosis.
研究结果表明这种每年一次的疗法能降低所有绝经期后患骨质疏松症各种类型骨折的风险。
Results of the study showed that treatment with zoledronic acid was very effective in reducing the incidence of all types of fractures in women with postmenopausal osteoporosis.
研究结果表明这种每年一次的疗法能降低所有绝经期后患骨质疏松症各种类型骨折的风险。
应用推荐